These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 32485921)
41. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389 [TBL] [Abstract][Full Text] [Related]
43. Effect of proton-pump inhibitor therapy on serum chromogranin a level. Pregun I; Herszényi L; Juhász M; Miheller P; Hritz I; Patócs A; Rácz K; Tulassay Z Digestion; 2011; 84(1):22-8. PubMed ID: 21304238 [TBL] [Abstract][Full Text] [Related]
44. Gastric graft-versus-host disease revisited: does proton pump inhibitor therapy affect endoscopic gastric biopsy interpretation? Welch DC; Wirth PS; Goldenring JR; Ness E; Jagasia M; Washington K Am J Surg Pathol; 2006 Apr; 30(4):444-9. PubMed ID: 16625089 [TBL] [Abstract][Full Text] [Related]
45. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300 [TBL] [Abstract][Full Text] [Related]
47. Chronic proton pump inhibition therapy in the diagnostic accuracy of serum pepsinogen I and gastrin concentrations to identify pernicious anaemia. Martín-Alcolea M; Rodríguez-Hernández I; Aldea M; Rosas I; Juncà J; Granada ML Clin Biochem; 2017 Jun; 50(9):481-484. PubMed ID: 28109748 [TBL] [Abstract][Full Text] [Related]
49. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway. Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126 [TBL] [Abstract][Full Text] [Related]
50. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572 [TBL] [Abstract][Full Text] [Related]
51. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC). Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926 [TBL] [Abstract][Full Text] [Related]
52. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach. Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. Lee MS; Helms TL; Feng N; Gay J; Chang QE; Tian F; Wu JY; Toniatti C; Heffernan TP; Powis G; Kwong LN; Kopetz S Oncotarget; 2016 Jun; 7(26):39595-39608. PubMed ID: 27167191 [TBL] [Abstract][Full Text] [Related]
55. Problems Associated with Deprescribing of Proton Pump Inhibitors. Helgadottir H; Bjornsson ES Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070 [TBL] [Abstract][Full Text] [Related]
56. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer. Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer. Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811 [TBL] [Abstract][Full Text] [Related]
58. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo. Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376 [TBL] [Abstract][Full Text] [Related]
59. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation. Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348 [TBL] [Abstract][Full Text] [Related]
60. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells. Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]